Displaying drugs 15176 - 15200 of 15429 in total
Carmegliptin
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
Haloxazolam
Experimental
Illicit
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid
Experimental
Mosapramine
Experimental
Dipipanone
Experimental
Illicit
2,3,4,5,6-Pentafluorobenzyl Alcohol
Experimental
Balanol Analog 2
Experimental
Iodobenzene
Experimental
AL7182
Experimental
(R)-Bicalutamide
Experimental
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea
Experimental
PAS219
Experimental
FR239087
Experimental
4-Fluorophenethyl Alcohol
Experimental
Phenacetin
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
1,3,5-trichlorobenzene
Experimental
Displaying drugs 15176 - 15200 of 15429 in total